Manufacturer's investigation conclusion: the reported pump thrombosis could not be confirmed through this evaluation, as no images were submitted for review and the device was not returned for evaluation.In addition, a direct correlation between the centrimag device and the reported hemorrhagic stroke could not be conclusively established through this evaluation.The centrimag device lot number and other specific case/patient information are not available.No product was evaluated under this complaint.The lot number or other identifying information of the product was not reported and was not able to be determined during the investigation.The centrimag blood pump instructions for use (ifu), rev.B, lists bleeding and thromboembolism as adverse events that may be associated with the centrimag circulatory support system under ¿adverse events¿.This ifu also provides the following warnings and cautions: ifu warning #7: it is intended that systemic anticoagulation be utilized while this device is in use.Anticoagulation levels should be determined by the physician based on risks and benefits to the patient.Ifu warning #10: frequent patient and device monitoring is recommended.Ifu caution #2: this device should only be used by persons thoroughly trained in extracorporeal circulation procedures.Ifu caution #9: monitor carefully for any signs of occlusion throughout the circuit.Ifu caution #15: always have a spare centrimag blood pump, back-up console, and equipment available for change out.No further information was provided.The manufacturer is closing the file on this event.
|